Neuraptive Therapeutics

Neuraptive Therapeutics
Neuraptive's lead product, AxoFuse, is a therapeutic for use during peripheral nerve surgery to improve outcomes for patients. AxoFuse has been shown to improve recovery of function and sensation in traumatic injury and has potential for the same across a wide array of reconstructive surgical protocols. The US market opportunity consists of ~1.4m eligible patients annually representing a >$5B global market.
Member count: 1-10
Total raised: $12.9M

Investors 2

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
20.12.2018Series A$

Mentions in press and media 4

25.07.2019Ben Frankl... Avisi is a pre-clinical ...--sep.benfra...
20.12.2018Neuraptive...Neuraptive Therapeutics, Inc.,
19.12.2018Neuraptive...Neuraptive Therapeutics, Inc. ...--citybizlis...
11.09.2017Tech Tools...Share Share on Facebook Share ...-Angela